EGFR Modulator Synthesis via PCl3 Thionation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing synthetic processes for EGFR modulator Compound A suffer from low yield, impurity issues, and impracticality for large-scale production due to the use of malodorous and moisture-sensitive reagents like Lawesson's reagent, and column chromatography purification steps.
Innovation Solution
A modified synthesis process involving halogenation or sulfonylation of intermediates, followed by the addition of a nucleophilic sulfuration reagent, and optional nitrogen-protecting group removal, without the use of moisture, and chromatography, and column chromatography, resulting in higher yields and practicality for large-scale production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If Lawesson's reagent is used in the synthesis process, then the thionation reaction can proceed, but the process becomes impractical for large-scale production due to malodorous and moisture-sensitive reagents
Solution Approach 1:
The patent replaces Lawesson's reagent with phosphorus trichloride (PCl3), a more stable, less odorous reagent that can be handled more easily in large-scale production. PCl3 is moisture-sensitive but can be used in situ without isolation, effectively replacing the problematic Lawesson's reagent while maintaining the thionation reaction efficiency.
Solution Approach 2:
The patent employs a composite approach by combining PCl3 with thionyl chloride (SOCl2) in the same reaction system. This composite reagent system achieves both thionation and chlorination in one pot, eliminating the need for separate purification steps and column chromatography, thereby improving practicality for large-scale production.
2Manufacturing precision
If column chromatography is used for purification, then product purity can be achieved, but the process becomes complex and impractical for large-scale production
Solution Approach 1:
The patent extracts and eliminates the column chromatography purification step from the synthesis process. By designing a reaction system where PCl3 and SOCl2 work together to produce the desired thionated and chlorinated products directly with high selectivity, the need for complex chromatographic purification is removed, making the process suitable for large-scale production while maintaining product purity.
Solution Approach 2:
The patent uses PCl3 as an intermediary reagent that facilitates the thionation reaction and simultaneously generates HCl in situ, which acts as a catalyst for the subsequent reactions. This intermediary approach allows multiple transformations to occur in sequence without isolation or purification steps, eliminating the need for column chromatography.
3Manufacturing precision
If the synthesis process uses multiple purification steps, then impurity issues can be addressed, but the yield and productivity decrease
Solution Approach 1:
The patent merges multiple reaction steps and purification operations into a single streamlined process. By using PCl3 and SOCl2 together in one pot, the synthesis achieves thionation, chlorination, and purification in sequence without isolation steps. This merging of operations maintains high yield while effectively removing impurities, significantly improving productivity for large-scale production.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The new process achieves higher yields and practicality for large-scale production of EGFR modulator Compound A, avoiding the use of malodorous and moisture-sensitive reagents, and eliminating the need for column chromatography.
Implementation Method 1
admixing Compound I and a halogenation reagent to form Compound II
Implementation Method 2
admixing Compound I and a sulfonylation reagent to form Compound II
Implementation Method 3
admixing Compound II and Compound III in the presence of a base to form Compound A
Implementation Method 4
admixing Compound II and a nucleophilic sulfuration reagent to form Compound IIA
Data Source
AI summary
Provided herein are processes for synthesizing compounds useful as EGFR modulators. In particular, provided herein are processes for synthesizing Compound A: